These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 3999028)

  • 1. Acute tolerance to furosemide diuresis in humans. Pharmacokinetic-pharmacodynamic modeling.
    Hammarlund MM; Odlind B; Paalzow LK
    J Pharmacol Exp Ther; 1985 May; 233(2):447-53. PubMed ID: 3999028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacodynamic modeling of furosemide tolerance after multiple intravenous administration.
    Wakelkamp M; Alván G; Gabrielsson J; Paintaud G
    Clin Pharmacol Ther; 1996 Jul; 60(1):75-88. PubMed ID: 8689815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of reduced effects of loop diuretics in healthy volunteers and in patients with renal disease.
    Sjöström P
    Scand J Urol Nephrol Suppl; 1988; 111():1-66. PubMed ID: 3201162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamic characterization of posture-related diuretic and saluretic responses to furosemide in humans.
    Okaniwa T; Echizen H; Ishizaki T; Kasao M; Iizuka T
    J Pharmacol Exp Ther; 1990 Nov; 255(2):716-23. PubMed ID: 2147037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of indomethacin on the pharmacokinetics, diuretic response and hemodynamics of furosemide in the dog.
    Data JL; Rane A; Gerkens J; Wilkinson GR; Nies AS; Branch RA
    J Pharmacol Exp Ther; 1978 Aug; 206(2):431-8. PubMed ID: 682123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steady state absorption kinetics and pharmacodynamics of furosemide in congestive heart failure.
    Chaturvedi PR; O'Donnell JP; Nicholas JM; Shoenthal DR; Waters DH; Gwilt PR
    Int J Clin Pharmacol Ther Toxicol; 1987 Mar; 25(3):123-8. PubMed ID: 3557737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormonal response to acute diuresis--a comparative study of furosemide and azosemide.
    Ogawa K; Hatano T; Yamamoto M; Matsui N
    Int J Clin Pharmacol Ther Toxicol; 1984 Jun; 22(6):284-90. PubMed ID: 6378806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Method of collecting urine and comparative investigation of quantities excreted by cats and dogs after administration of furosemide.
    Klatt P; Muschaweck R; Bossaller W; Magerkurth KO; Vanderbeke O
    Am J Vet Res; 1975 Jul; 36(7):919-23. PubMed ID: 1147356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent aquaretic agent. A novel nonpeptide selective vasopressin 2 antagonist (OPC-31260) in men.
    Ohnishi A; Orita Y; Okahara R; Fujihara H; Inoue T; Yamamura Y; Yabuuchi Y; Tanaka T
    J Clin Invest; 1993 Dec; 92(6):2653-9. PubMed ID: 8254021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the diuretic effect of furosemide mixed with human albumin or fresh frozen plasma for patients with hypoalbuminemia in the intensive care unit.
    Hsu CW; Lin SL; Sun SF; Chu KA; Chung HM; Chang HW
    J Nephrol; 2006; 19(5):621-7. PubMed ID: 17136691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative study of pharmacokinetics and effects on urinary secretion of electrolytes of furosemide and furosemide-amiloride in healthy subjects].
    Kantelip JP; Aiache JM; Beyssac E; Abella ML
    Therapie; 1991; 46(6):475-9. PubMed ID: 1819153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Furosemide pharmacokinetics and pharmacodynamics following gastroretentive dosage form administration to healthy volunteers.
    Klausner EA; Lavy E; Stepensky D; Cserepes E; Barta M; Friedman M; Hoffman A
    J Clin Pharmacol; 2003 Jul; 43(7):711-20. PubMed ID: 12856384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative pharmacokinetics and pharmacodynamics of furosemide in Middle Eastern and in Asian subjects.
    Abou-Auda HS
    Int J Clin Pharmacol Ther; 1998 May; 36(5):275-81. PubMed ID: 9629992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acute effects of bumetanide in healthy subjects. A comparative study with furosemide (author's transl)].
    Ortź González A; Méndez Martin A
    Med Clin (Barc); 1979 Mar; 72(6):259-64. PubMed ID: 379471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary elimination kinetics and diuretic effect of intravenous furosemide in nephrotic children.
    Prandota J
    Dev Pharmacol Ther; 1982; 5(1-2):98-108. PubMed ID: 7151641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Negative modulation of nitric oxide production by neurotensin as a putative mechanism of the diuretic action of SR 48692 in rats.
    Croci T; Landi M; Gully D; Maffrand JP; Le Fur G; Manara L
    Br J Pharmacol; 1997 Apr; 120(7):1312-8. PubMed ID: 9105707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Input rate as a major determinant of furosemide pharmacodynamics: influence of fluid replacement and hypoalbuminemia.
    Castañeda-Hernández G; Vergés J; Pichette V; Héroux L; Caillé G; du Souich P
    Drug Metab Dispos; 2000 Mar; 28(3):323-8. PubMed ID: 10681377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of furosemide oral solution versus furosemide tablets on diuresis and electrolytes in patients with moderate congestive heart failure.
    Cohen N; Golik A; Dishi V; Zaidenstein R; Weissgarten J; Averbukh Z; Modai D
    Miner Electrolyte Metab; 1996; 22(4):248-52. PubMed ID: 8807629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical investigations on the pharmacology of azosemide (SK-110) in comparison with furosemide in healthy volunteers.
    Kuzuya F; Sugino N; Yoshizumi K; Goto U; Oshima K
    Int J Clin Pharmacol Ther Toxicol; 1984 Jun; 22(6):291-9. PubMed ID: 6746152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of furosemide upon extracellular fluid volume depletion and kidney denervation in rats.
    Piryova B
    Acta Physiol Pharmacol Bulg; 1985; 11(3):10-6. PubMed ID: 3832788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.